Glucose toxicity contributes to progressive β-cell failure and the development of overt diabetes. Oxidative stress is an important aspect of glucose toxicity in pancreatic β-cells. We investigated whether the flavonoid apigenin protects pancreatic β-cells from 2-deoxy-D-ribose (dRib)-induced oxidative cell damage. HIT-T15 pancreatic β-cells were cultured with or without apigenin in the presence of dRib. Time-and dosedependent cell viability was monitored using a cell counting kit (CCK-8), while the induction of apoptosis was analyzed using a cell death enzyme-linked immunosorbent assay (ELISA) kit. Mitochondrial membrane potential (ΔΨ m ) was determined using the JC-1 kit. Intracellular oxidative stress was measured by fluorometric analysis of DCFH oxidation using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) as the probe. In addition, the DNA binding activity of the oxidative stress-related transcriptional factors nuclear factor-κB (NF-κB) and activator protein 1 (AP-1) were analyzed. dRib reduced cell survival and ΔΨ m , while it markedly increased intracellular levels of reactive oxygen species (ROS), apoptosis, and the activity of the oxidative stress-related transcription factors NF-κB and AP-1. However, pretreatment of cells with apigenin attenuated all the dRib-induced effects. The anti-oxidants, N-acetyl-L-cysteine (NAC) and alpha lipoic acid (ALA), also prevented both dRib-induced oxidative damage and activation of NF-κB and AP-1. Taken together, these results suggest that apigenin attenuates dRib-induced cell damage in pancreatic β-cells via oxidative stressrelated signaling.
Key words oxidative stress; apigenin; 2-deoxy-D-ribose; diabetes; pancreatic β-cellOxidative stress is known to be a major contributor to the development of overt diabetes and its associated complications.1) Oxidative stress results from a persistent imbalance between antioxidant defenses and the production of highly reactive oxygen species (ROS).2) ROS are normal byproducts of cellular metabolism. However, a marked increase in glucose metabolism could lead to excessive ROS production, which could contribute to the development of diabetic complications. In particular, pancreatic β-cells express low levels of antioxidant enzymes and do not up-regulate these enzymes upon exposure to high concentrations of glucose.3) Thus, increased ROS production in the presence of low antioxidant defense levels could result in ROS accumulation, which would lead to the oxidative pancreatic β-cell damage that is partly responsible for diabetes. Nuclear factor-κB (NF-κB) and activator protein 1 (AP-1) are 2 redox-sensitive transcription factors that can be regulated by oxidative stress. [4][5][6] By activating these transcription factors in isolated peripheral mononuclear cells of diabetic patients, ROS are also involved in the pathogenesis of diabetic nephropathy. 7) In addition, activation of NF-κB correlates with the quality of glycemic control and has been shown to be reduced by treatment with antioxidants in a diabetic animal model and diabetic pa...